All Stories

  1. A simian hemorrhagic fever virus isolate from persistently infected baboons efficiently induces hemorrhagic fever disease in Japanese macaques

    Article • Virology, January 2015, Elsevier

    Dr Margo A Brinton

  2. Corrigendum to “Each of the eight simian hemorrhagic fever virus minor structural proteins is functionally important” [Virology 462–463 (2014) 351–362]

    Article • Virology, September 2014, Elsevier

    Dr Margo A Brinton

  3. Each of the eight simian hemorrhagic fever virus minor structural proteins is functionally important

    Article • Virology, August 2014, Elsevier

    Dr Margo A Brinton

  4. Genetic Resistance to Flaviviruses

    Article • Monoclonal Antibodies in Immunodiagnosis and Immunotherapy, June 2014, Mary Ann Liebert Inc

    Dr Margo A Brinton

  5. Dimeric Structure of Pseudokinase RNase L Bound to 2-5A Reveals a Basis for Interferon-Induced Antiviral Activity

    Article • Molecular Cell, January 2014, Elsevier

    Dr Margo A Brinton

  6. Replication Cycle and Molecular Biology of the West Nile Virus

    Article • Viruses, December 2013, MDPI AG

    Dr Margo A Brinton

  7. Differential Responses of Disease-Resistant and Disease-Susceptible Primate Macrophages and Myeloid Dendritic Cells to Simian Hemorrhagic Fever Virus Infection

    Article • Journal of Virology, December 2013, ASM Journals

    Dr Margo A Brinton

  8. Increased Early RNA Replication by Chimeric West Nile Virus W956IC Leads to IPS-1-Mediated Activation of NF- B and Insufficient Virus-Mediated Counteraction of the Resulting Canonical Type I Interferon Signaling

    Article • Journal of Virology, May 2013, ASM Journals

    Dr Margo A Brinton

  9. Identification of cis-Acting Nucleotides and a Structural Feature in West Nile Virus 3'-Terminus RNA That Facilitate Viral Minus Strand RNA Synthesis

    Article • Journal of Virology, May 2013, ASM Journals

    Dr Margo A Brinton

  10. Type 1 IFN-independent activation of a subset of interferon stimulated genes in West Nile virus Eg101-infected mouse cells

    Article • Virology, April 2012, Elsevier

    Dr Margo A Brinton

  11. Activation of Oas1a gene expression by type I IFN requires both STAT1 and STAT2 while only STAT2 is required for Oas1b activation

    Article • Virology, April 2012, Elsevier

    Dr Margo A Brinton

  12. Single nucleotide polymorphism in the promoter region of the CD209 gene is associated with human predisposition to severe forms of tick-borne encephalitis

    Article • Antiviral Research, January 2012, Elsevier

    Dr Margo A Brinton

  13. Host Genetic Risk Factors for West Nile Virus Infection and Disease Progression

    Article • PLoS ONE, September 2011, PLOS

    Dr Margo A Brinton

  14. West Nile virus (WNV) genome RNAs with up to three adjacent mutations that disrupt long distance 5′–3′ cyclization sequence basepairs are viable

    Article • Virology, March 2011, Elsevier

    Dr Margo A Brinton

  15. Variability in the 2′‐5′‐Oligoadenylate Synthetase Gene Cluster Is Associated with Human Predisposition to Tick‐Borne Encephalitis Virus–Induced Disease

    Article • The Journal of Infectious Diseases, December 2010, Oxford University Press (OUP)

    Dr Margo A Brinton

  16. Viscerotropic disease following yellow fever vaccination in Peru

    Article • Vaccine, October 2009, Elsevier

    Dr Thomas P. Monath, Dr Margo A Brinton

  17. Characterization of equine and other vertebrate TLR3, TLR7, and TLR8 genes

    Article • Immunogenetics, July 2009, Springer Science + Business Media

    Dr Margo A Brinton

  18. Molecular Biology of West Nile Virus

    Article • January 2009, Springer Science + Business Media

    Dr Margo A Brinton

  19. Case of Yellow Fever Vaccine–Associated Viscerotropic Disease with Prolonged Viremia, Robust Adaptive Immune Responses, and Polymorphisms in CCR5 and RANTES Genes

    Article • The Journal of Infectious Diseases, August 2008, Oxford University Press (OUP)

    Dr Margo A Brinton

  20. Fatal multiorgan failure due to yellow fever vaccine-associated viscerotropic disease

    Article • Vaccine, December 2007, Elsevier

    Dr Margo A Brinton

  21. Knock-in of the Oas1br allele into a flavivirus-induced disease susceptible mouse generates the resistant phenotype

    Article • Virology, November 2007, Elsevier

    Dr Margo A Brinton

  22. Interactions between the West Nile virus capsid protein and the host cell-encoded phosphatase inhibitor, I2PP2A

    Article • Cellular Microbiology, November 2007, Hindawi Publishing Corporation

    Dr Margo A Brinton

  23. Characterization of the equine 2'-5' oligoadenylate synthetase 1 (OAS1) and ribonuclease L (RNASEL) innate immunity genes

    Article • BMC Genomics, September 2007, Springer Science + Business Media

    Dr Margo A Brinton

  24. The Mammalian 2′-5′ Oligoadenylate Synthetase Gene Family: Evidence for Concerted Evolution of Paralogous Oas1 Genes in Rodentia and Artiodactyla

    Article • Journal of Molecular Evolution, October 2006, Springer Science + Business Media

    Dr Margo A Brinton

  25. Comparative analysis of vertebrate EIF2AK2 (PKR) genes and assignment of the equine gene to ECA15q24–q25 and the bovine gene to BTA11q12–q15

    Article • Génétique Sélection Évolution, September 2006, Springer Science + Business Media

    Dr Margo A Brinton

  26. Two cellular proteins that interact with a stem loop in the simian hemorrhagic fever virus 3′(+)NCR RNA

    Article • Virus Research, May 2005, Elsevier

    Dr Margo A Brinton

  27. Recombination and flavivirus vaccines: a commentary

    Article • Vaccine, April 2005, Elsevier

    Dr Thomas P. Monath, Dr Margo A Brinton

  28. The majority of the nucleotides in the top loop of the genomic 3′ terminal stem loop structure are cis-acting in a West Nile virus infectious clone

    Article • Virology, January 2005, Elsevier

    Dr Margo A Brinton

  29. Genetic resistance to flaviviruses

    Article • January 2003, Elsevier

    Dr Margo A Brinton

  30. The Molecular Biology of West Nile Virus: A New Invader of the Western Hemisphere

    Article • Annual Review of Microbiology, October 2002, Annual Reviews

    Dr Margo A Brinton

  31. Evolution of the Mouse Polyubiquitin-C Gene

    Article • Journal of Molecular Evolution, August 2002, Springer Science + Business Media

    Dr Margo A Brinton

  32. West Nile Virus

    Article • January 2002, Wiley

    Dr Margo A Brinton

  33. Host Factors Involved in West Nile Virus Replication

    Article • Annals of the New York Academy of Sciences, December 2001, Wiley

    Dr Margo A Brinton

  34. An Infectious Clone of the West Nile Flavivirus

    Article • Virology, March 2001, Elsevier

    Dr Margo A Brinton

  35. Identification of Cell Proteins that Bind to the SHFV 3′(+)NCR

    Article • January 2001, Springer Science + Business Media

    Dr Margo A Brinton

  36. Immune mediated and inherited defences against flaviviruses

    Article • Clinical and Diagnostic Virology, July 1998, Elsevier

    Dr Margo A Brinton

  37. Definition of an Epitope on NS3 Recognized by Human CD4+Cytotoxic T Lymphocyte Clones Cross-Reactive for Dengue Virus Types 2, 3, and 4

    Article • Virology, January 1998, Elsevier

    Dr Margo A Brinton

  38. Cell Proteins Bind to A 67 Nucleotide Sequence within the 3’ Noncoding Region (NCR) of Simian Hemorrhagic Fever Virus (SFV) Negative-Strand RNA

    Article • January 1998, Springer Science + Business Media

    Dr Margo A Brinton

  39. Evidence for the Existence of a Pseudoknot Structure at the 3‘ Terminus of the Flavivirus Genomic RNA

    Article • Biochemistry, January 1996, American Chemical Society (ACS)

    Dr Margo A Brinton

  40. Positive-Strand RNA Viruses

    Article • January 1994, Springer Science + Business Media

    Dr Margo A Brinton

  41. Identification of amino acids located in the antibody binding sites of human hepatitis a virus

    Article • Virology, December 1992, Elsevier

    Dr Margo A Brinton

  42. Varying role of alpha/beta interferon in the antiviral efficacy of synthetic immunomodulators against semliki forest virus infection

    Article • Antiviral Research, March 1991, Elsevier

    Dr Margo A Brinton

  43. Comparative Therapeutic Efficacy of Recombinant Interferons-α, -β, and -γ Against Alphatogavirus, Bunyavirus, Flavivirus, and Herpesvirus Infections

    Article • Journal of Interferon Research, June 1990, Mary Ann Liebert Inc

    Dr Margo A Brinton

  44. The 3′ terminus of lactate dehydrogenase-eVirus genome RNA does not contain togavirus or flavivirus conserved sequences

    Article • Virology, October 1989, Elsevier

    Dr Margo A Brinton

  45. Sequence and secondary structure analysis of the 5′-terminal region of flavivirus genome RNA

    Article • Virology, February 1988, Elsevier

    Dr Margo A Brinton

  46. Comparative study of various immunomodulators for macrophage and natural killer cell activation and antiviral efficacy against exotic RNA viruses

    Article • International Journal of Immunopharmacology, January 1988, Elsevier

    Dr Margo A Brinton

  47. Detection of viral-specific nucleic acid and intracellular virions in ventral horn neurons of lactate dehydrogenase-elevating virus infected C58 mice

    Article • Microbial Pathogenesis, December 1986, Elsevier

    Dr Margo A Brinton

  48. The 3′-nucleotides of flavivirus genomic RNA form a conserved secondary structure

    Article • Virology, August 1986, Elsevier

    Dr Margo A Brinton

  49. LACTATE DEHYDROGENASE–ELEVATING VIRUS

    Article • January 1986, Elsevier

    Dr Margo A Brinton

  50. Replication of Flaviviruses

    Article • January 1986, Springer Science + Business Media

    Dr Margo A Brinton

  51. Enhancement of encephalomyeloradiculitis in mice sensitized with spinal cord tissue and infected with lactate dehydrogenase-elevating virus

    Article • Journal of Neuroimmunology, January 1985, Elsevier

    Dr Margo A Brinton

  52. Characterization of West Nile virus persistent infections in genetically resistant and susceptible mouse cells II. Generation of temperature-sensitive mutants

    Article • Virology, January 1985, Elsevier

    Dr Margo A Brinton

  53. Host Genes that Influence Susceptibility to Viral Diseases

    Article • January 1984, Springer Science + Business Media

    Dr Margo A Brinton

  54. A replication-efficient mutant of West Nile virus is insensitive to DI particle interference

    Article • Virology, August 1983, Elsevier

    Dr Margo A Brinton

  55. Genetically Controlled Resistance to Viruses

    Article • January 1983, Springer Science + Business Media

    Dr Margo A Brinton

  56. Lactate Dehydrogenase-Elevating Virus

    Article • January 1982, Elsevier

    Dr Margo A Brinton

  57. Characterization of West Nile virus persistent infections in genetically resistant and susceptible mouse cells I. Generation of defective nonplaquing virus particles

    Article • Virology, January 1982, Elsevier

    Dr Margo A Brinton

  58. Genetically Controlled Resistance to Flavivirus and Lactate-Dehydrogenase-Elevating Virus-Induced Disease

    Article • January 1981, Springer Science + Business Media

    Dr Margo A Brinton

  59. Non-Arbo Togaviruses

    Article • January 1980, Elsevier

    Dr Margo A Brinton

  60. GENETICALLY CONTROLLED RESISTANCE TO TOGAVIRUSES

    Article • January 1980, Elsevier

    Dr Margo A Brinton

  61. Actinomycin D Cytotoxicity for Mouse Peritoneal Macrophages and Effect on Lactate Dehydrogenase-Elevating Virus Replication

    Article • Intervirology, January 1979, Karger Publishers

    Dr Margo A Brinton

  62. Lactate dehydrogenase-elevating virus replication, maturation, and viral RNA synthesis in primary mouse macrophage cultures

    Article • Virology, May 1975, Elsevier

    Dr Margo A Brinton